Most Americans in a new poll said they probably won’t get an updated COVID-19 vaccine. The Pew Research Center survey found ...

A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

Ongoing studies shows why covid 19 protection wanes over time. Know the factors behind waning immunity, why booster doses are ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

“There is not one college or university that has yet to be held accountable for the countless injuries and deaths that have ...

Read the latest on CDC’s 2024-2025 COVID-19 vaccine recommendation in @CDCMMWR ... As of last December, just 17 percent of ...

Jackson County officials are locked in a heated debate over how to allocate $70 million in COVID-19 relief funds, with a significant disagreement centering on upgrading a downtown Kansas City building ...

Ahead of his second presidential term, which begins on Jan. 20 of next year, President-elect Donald Trump has begun declaring his nominations for key Cabinet and White House staff. Positions ...

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

GeoVax Labs (GOVX) announced the completion of an interim data review by the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 ...